LabAnswer Selects John F. Conway as Director of R & D Strategy
News Feb 25, 2014
LabAnswer, one of the nation’s leading laboratory informatics consultancies, has announced the formation of a new position, Director of R & D Strategy and named John F. Conway to the position. John will strategize and architect scientific data management systems to streamline R&D processes for leading life science, chemical, consumer product, and process manufacturing organizations.
John comes to LabAnswer with 20 years of R&D experience. Most recently, he was with Schrödinger, LLC, where he was Vice President of Professional Services and Solutions. John’s focus was to expand Schrodinger’s footprint in scientific informatics.
Previously, John was Global Director of Scientific Informatics and Solutions at Accelrys, Inc. It was there that John helped bring both the concept of Biological Entity Registration and Next Generation LIMS to market. In addition, John and his teams were responsible for building small and large molecule design environments. Before he joined Accelrys, he was the Philadelphia Site Head, Global Chair of the Structural Biology Domain, and head of US Lab Automation for the Discovery Informatics Department at GlaxoSmithKline, Inc. Prior to GSK, John spent many years at Merck and Co., Inc. with varying roles in biological and chemical informatics as well as computational science methods and modeling.
John’s early career includes serving as an analytical biochemist at Tektagen, Inc. (now Charles River Laboratories), a Senior Forensic Scientist at the Pennsylvania State Police, and Co-Founder of Avecon, a diverse diagnostics company. His education includes biochemistry and molecular biology at Pennsylvania State University and Lehigh University.
“I could not be more pleased and excited knowing that I will be helping LabAnswer clients to rethink how to manage the R&D informatics space,” states Conway.
“We are pleased to have someone of John’s stature join our team. In his new role at LabAnswer, John and his team are solely focused on architecting the best possible systems for our clients with an unbiased approach to drive superior outcomes,” adds Mark Everding, LabAnswer President / CEO.
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
Researchers Move Closer to Completely Optical Artificial Neural NetworkNews
Researchers have shown that it is possible to train artificial neural networks directly on an optical chip. The significant breakthrough demonstrates that an optical circuit can perform a critical function of an electronics-based artificial neural network and could lead to less expensive, faster and more energy efficient ways to perform complex tasks such as speech or image recognition.
Big Data Study Targets Genomic Dark Matter from Ocean Floor to Gut FloraNews
An international team led by computational biologist Fran Supek at IRB Barcelona develop a machine learning method to predict unknown gene functions of microbes.The system examines and compares ‘big data’ available on the metagenomes of human and environmental microbiomes.READ MORE